Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
17.35
+0.54 (3.21%)
At close: Jun 22, 2026, 4:00 PM EDT
17.01
-0.34 (-1.96%)
After-hours: Jun 22, 2026, 5:13 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $175.38 million as of June 22, 2026. Its market cap has increased by 324.64% in one year.
Market Cap
175.38M
Enterprise Value
223.38M
1-Year Change
324.64%
Ranking
Category
Stock Price
$17.35
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $175.38M, a decrease of -47.85%. That is a compound annual growth rate of -10.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 175.38M | 224.19% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 1.10B |
| OPKO Health | 1.07B |
| Castle Biosciences | 640.57M |
| Fulgent Genetics | 511.21M |
| Myriad Genetics | 428.79M |
| Prenetics Global | 344.98M |
| Insight Molecular Diagnostics | 175.65M |
| Exagen | 109.69M |